Back to Search Start Over

Active Biotech provides status update in the portfolio projects

Source :
ICT Monitor Worldwide. June 4, 2020
Publication Year :
2020

Abstract

(GlobeNewswire) - Lund, June 3, 2020 - Active Biotech (Nasdaq Stockholm: ACTI) today provides a status update in the projects following the new direction communicated in early February. This abbreviated [...]

Subjects

Subjects :
Active Biotech AB -- Planning
Durvalumab -- Planning
Financial markets
Biotechnology
Ixazomib
Company business planning
Telecommunications industry

Details

Language :
English
Database :
Gale General OneFile
Journal :
ICT Monitor Worldwide
Publication Type :
News
Accession number :
edsgcl.625718807

Tools

Authors Abstract Subjects Details